Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neuropsychiatrisches Zentrum Hamburg-Altona is a Hamburg-based outpatient neuropsychiatric care provider organized as a Medizinisches Versorgungszentrum (MVZ), offering diagnosis and treatment across neurology, psychiatry, psychotherapy, and related specialties. The center emphasizes ambulatory care and operates specialized clinics for adult ADHD, autism spectrum disorder, and other neuropsychiatric conditions, alongside broader neurological and psychiatric services. It also provides psychotherapeutic individual and group treatment and offers transcranial magnetic stimulation as an innovative non-drug therapeutic option for depression and related conditions. The organization appears to function primarily as a clinical healthcare services business rather than a drug-development biotech or pharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neuropsychiatrisches Zentrum Hamburg-Altona.